financetom
Business
financetom
/
Business
/
Tata Consumer Products ties up with Domino''s Pizza, Zomato to deliver essential goods
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Consumer Products ties up with Domino''s Pizza, Zomato to deliver essential goods
May 7, 2020 9:14 AM

Tata Consumer Products (TCPL) on Thursday said it has partnered with food delivery platforms like Domino''s Pizza and Zomato to strengthen its direct distribution model and ensure steady supply of its essential products.

Share Market Live

NSE

“Through these partnerships, we intend to safeguard people''s health by giving them alternate channels to buy our food and beverage offerings,” TCPL Managing Director and CEO Sunil D''Souza said in a statement.

The partnerships leverage complementary strengths to ensure essential products reach the doorsteps of consumers who need them, he said.

These channel partnerships have been done in a phased manner, with Flipkart being the first e-commerce platform to enable the availability of its essential products in Mumbai, Bengaluru and Delhi.

On Domino''s Pizza app, this service will be available under “Domino''s Essentials” for consumers in Delhi, Mumbai, Bengaluru, Chennai, Hyderabad and Kolkata.

Zomato is currently operational in over 60 cities pan-India enabling Tata Consumer''s products to reach consumers across the country.

In an alternate distribution model, Tata Consumer Products'' distributors will list as marketplace sellers on Flipkart, Domino''s Pizza, Zomato and other platforms.

Additionally, Tata Consumer Products has also started the delivery of its food products through its own nutrition and e-commerce platform, Tata NutriKorner, in two phases.

Certain pin-codes in Delhi have already been activated as part of phase one, later phases will cover the whole of Delhi in a couple of weeks, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly set for strong quarter after Novo profit warning
Lilly set for strong quarter after Novo profit warning
Jul 29, 2025
(Reuters) -Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S. market and has faced less competition...
General Dynamics Insider Sold Shares Worth $1,717,312, According to a Recent SEC Filing
General Dynamics Insider Sold Shares Worth $1,717,312, According to a Recent SEC Filing
Jul 29, 2025
03:56 PM EDT, 07/29/2025 (MT Newswires) -- Rudy F De Leon, Director, on July 28, 2025, sold 5,490 shares in General Dynamics ( GD ) for $1,717,312. Following the Form 4 filing with the SEC, De Leon has control over a total of 5,483 common shares of the company, with 5,483 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/40533/000095017025099603/xslF345X05/ownership.xml Price: 314.12, Change:...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Lilly set for strong quarter after Novo profit warning
Lilly set for strong quarter after Novo profit warning
Jul 29, 2025
July 29 (Reuters) - Investors and analysts say they expect Eli Lilly ( LLY ) to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year outlook and updates on an experimental obesity drug to gauge the U.S. drugmaker's longer-term health. Lilly's weight-loss drug Zepbound leads the U.S....
Copyright 2023-2026 - www.financetom.com All Rights Reserved